Clinical Trials
26 trialsNCT02725424 2022-08-17
MATCH
ChineseAMS
Phase 2 Completed
NCT04247984 2022-03-11
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
ChineseAMS
Phase 2 Completed
NCT02992886 2021-09-09
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
ChineseAMS
Phase 2 Completed
NCT01463605 2021-02-04
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial
ChineseAMS
Phase 2 Completed
NCT03083613 2021-02-01
Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT03415802 2021-02-01
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Completed
NCT03443661 2021-02-01
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer
ChineseAMS
Phase 2 Completed
NCT03830606 2021-02-01
The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT03535961 2020-12-02
Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
ChineseAMS
Phase 2 Completed
NCT04002284 2020-07-29
Anlotinib in Metastatic HER2 Negative Breast Cancer
ChineseAMS
Phase 2 Completed
NCT01187238 2020-07-16
The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma
ChineseAMS
Phase 2 Completed
NCT03572829 2020-07-15
Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC
ChineseAMS
Phase 2 Completed
NCT02301481 2019-10-16
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT01520324 2019-02-08
Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy
CosmoTech
Phase 2 Completed
NCT02295774 2018-11-05
Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
CosmoTech
Phase 2 Completed
NCT02276248 2017-08-16
Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma
ChineseAMS
Phase 2 Completed
NCT02654106 2017-06-06
SRTRBM
ChineseAMS
Phase 2 Completed
NCT02460744 2015-06-02
2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer
PIMERIndia
Phase 2 Completed
NCT02133612 2015-04-14
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 2 Completed
NCT02370849 2015-02-25
Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT02323737 2014-12-30
Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer
ChineseAMS
Phase 2 Completed
NCT01531452 2014-12-04
The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer
ChineseAMS
Phase 2 Completed
NCT01797900 2014-09-10
The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
ChineseAMS
Phase 2 Completed
NCT01444521 2014-05-06
Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer
ChineseAMS
Phase 2 Completed
NCT00600587 2013-06-25
Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)
GuangdongPPH
Phase 2 Completed
NCT00530764 2013-06-20
SPRAY
GWPharm
Phase 2 Completed